01 October 2003 14:52 [Source: ICIS news]
HOUSTON (CNI)--Troubled US drug maker Schering-Plough (S-P) said Wednesday the US Attorney in New Jersey has ended its investigation of the company's manufacturing operations in Puerto Rico.
Kenilworth, New Jersey-based S-P has been cited for quality control problems at its facilities in Puerto Rico and New Jersey and paid a $500m (Euro427.4m) fine last year following a US Food and Drug Administration (FDA) criminal investigation.
Said Fred Hassan, S-P chairman and chief executive: "It is vitally important to resolve the legal and regulatory matters facing our company. I am glad we were able to put this legacy issue behind us as we move to create a new Schering-Plough."
Schering-Plough is a research-based company engaged in the discovery, development, manufacturing and marketing of pharmaceutical products.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|